Back to Insider Trading View Full Company Profile

PCSA

MODERATE

Processa Pharmaceuticals, Inc.

CIK: 0001533743

Buy (70% confidence)

Last activity: 4 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$4.53M

Trend Signals

CEO Buy STRONG

CEO buying activity

4 days ago

CFO Buy STRONG

CFO buying activity

4 days ago

Insider Roster (9 total, 9 active)

Insider Buys Sells Net Value Holdings
SKIBSTED RUSSELL
Chief Financial Officer
1 0 $6K
2,324 shares
$6K
Baluch Khoso
OTHER
1 0 $6K
2,325 shares
$6K
Ng George K
Chief Executive Officer
1 0 $5K
3,649 shares
$9K
Bigora Sian
Chief Development Officer
1 0 $5K
3,711 shares
$9K
Pannu Geraldine
OTHER
1 0 $5K
2,188 shares
$6K
Guy Wendy
Chief Administrative Officer
1 0 $5K
3,110 shares
$8K
Young David
Pres. Research & Development
1 0 $5K
10,562 shares
$27K
Lin Patrick
Chief Business - Strategy Off
1 0 $4K
3,356 shares
$9K
Neal James R
OTHER
1 0 $2K
818 shares
$2K

Recent Transactions

BUY SKIBSTED RUSSELL (Chief Financial Officer)

2,324 shares @ $2.54

$6K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Baluch Khoso (OTHER)

2,269 shares @ $2.54

$6K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Ng George K (Chief Executive Officer)

2,136 shares @ $2.54

$5K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Bigora Sian (Chief Development Officer)

2,107 shares @ $2.54

$5K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Pannu Geraldine (OTHER)

2,072 shares @ $2.54

$5K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Guy Wendy (Chief Administrative Officer)

1,854 shares @ $2.54

$5K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Young David (Pres. Research & Development)

1,810 shares @ $2.54

$5K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Lin Patrick (Chief Business - Strategy Off)

1,603 shares @ $2.54

$4K

Mar 31, 2026

Conviction: | View SEC Filing →
BUY Neal James R (OTHER)

789 shares @ $2.54

$2K

Mar 31, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.